Latest | Instant news on finance, ETFs, IPOs etc. _第229页

10:02

【iShares Core MSCI AC Asia ex Japan Index ETF (03010.HK) Falls 1.13% in Morning Trade, AUM at HKD 43.337 Billion】NewTimeSpace News: As of 10:00 on July 2, iShares Core MSCI AC Asia ex Japan Index ETF (03010.HK) declined 1.13%, with the latest price at HKD 89.640.

Tag： iShares Core MSCI AC Asia ex Japan Index ETF ETF 03010.HK

09:57

【Global X Asia Semiconductor Etf (03119.HK) Falls 4.64% in Morning Trade, Latest Price at HKD 197.300】NewTimeSpace News: As of 09:54 on July 2, Global X Asia Semiconductor Etf (03119.HK) declined 4.64%, with the latest price at HKD 197.300.

Tag： Global X Asia Semiconductor Etf ETF 03119.HK

09:54

【GREEN ECONOMY(01315.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 8.76 million, YoY decrease of 43.21%】NewTimeSpace (newtimespace.com) News, July 01, 2026, GREEN ECONOMY(01315.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 2.18 billion, decreased by 11.21% YoY

Tag： GREEN ECONOMY 01315.HK NewTimeSpace

09:51

【CSOP Hang Seng Biotech ETF (03174.HK) Rises 5.70% in Morning Trade, Latest NAV at HKD 3.038】NewTimeSpace News: As of 09:49 on July 2, CSOP Hang Seng Biotech ETF (03174.HK) gained 5.70%, with the latest price at HKD 3.226.

Tag： CSOP Hang Seng Biotech ETF ETF 03174.HK

09:51

【UNITY GP HLDGS(01539.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 66.72 million, YoY increase of 87.78%】NewTimeSpace (newtimespace.com) News, July 01, 2026, UNITY GP HLDGS(01539.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 118.69 million, decreased by 24.58% YoY

Tag： UNITY GP HLDGS 01539.HK NewTimeSpace

09:49

【NIU HOLDINGS(08619.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 138.85 million, turned into a loss from a profit YoY】NewTimeSpace (newtimespace.com) News, July 02, 2026, NIU HOLDINGS(08619.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 77.95 million, decreased by 25.25% YoY

Tag： NIU HOLDINGS 08619.HK NewTimeSpace

09:48

【Ishares Core Hang Seng Index Etf (03115.HK) Rises 2.10% in Morning Trade, Latest Price at HKD 85.580】NewTimeSpace News: As of 09:46 on July 2, Ishares Core Hang Seng Index Etf (03115.HK) gained 2.10%, with the latest price at HKD 85.580.

Tag： Ishares Core Hang Seng Index Etf ETF 03115.HK

09:44

【CA CULTURAL(01566.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 99.94 million, loss widened by 202.45% YoY】NewTimeSpace (newtimespace.com) News, July 01, 2026, CA CULTURAL(01566.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 360.44 million, decreased by 1.78% YoY

Tag： CA CULTURAL 01566.HK NewTimeSpace

09:43

【RICHLY FIELD(00313.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 213.53 million, loss narrowed by 14.5% YoY】NewTimeSpace (newtimespace.com) News, July 02, 2026, RICHLY FIELD(00313.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 41.88 million, decreased by 66% YoY

Tag： RICHLY FIELD 00313.HK NewTimeSpace

09:40

【ChinaAMC HSI ESG ETF (03403.HK) Rises 1.61% in Morning Trade, Turnover at HKD 2.8518 Million】NewTimeSpace News: As of 09:38 on July 2, ChinaAMC HSI ESG ETF (03403.HK) gained 1.61%, with the latest price at HKD 47.960.

Tag： the ChinaAMC HSI ESG ETF 03403.HK ETF

08:33

【Insilico Medicine (03696.HK): Strategic Partnership with Takeda for AI-Driven Drug Discovery with Total Value Up to USD 600 Million】NewTimeSpace News: Insilico Medicine disclosed in a voluntary announcement dated July 2 that the Group has entered into a strategic cooperation with Takeda Pharmaceutical. Leveraging Insilico Medicine’s proprietary end-to-end Pharma.AI platform, both parties will jointly advance candidate drug research and development in therapeutic areas selected by Takeda.

Tag： Insilico Medicine 03696.HK

08:30

【MANYCORE TECH (00068.HK): Grant of 1,130,000 Restricted Share Units to 24 Employees】NewTimeSpace News: MANYCORE TECH announced on July 2 that pursuant to its post-IPO restricted share unit scheme, the Company granted an aggregate of 1,130,000 restricted share units to 24 eligible employees at a nil subscription price.

Tag： MANYCORE TECH 00068.HK

08:22

【People's Insurance Company of China Group (01339.HK): Appointment Qualification of Vice President Zhang Daoming Approved by the State Administration of Financial Regulation】NewTimeSpace News: PICC Group announced on July 2 that the Company has recently received an official reply from the State Administration of Financial Regulation, approving the appointment qualification of Mr. Zhang Daoming as Vice President of the Company.

Tag： Peoples Insurance Company of China Group 01339.HK

08:19

【Laekna, Inc.(02105.HK): Proposed Share Buyback Plus Senior Management Share Purchases Up to Aggregate HK$56 Million】NewTimeSpace News: Laekna, Inc. disclosed in a voluntary announcement dated July 2 that its Board of Directors approved an on-market share repurchase programme on July 1, 2026. Meanwhile, Dr. Lü Xiangyang, Chairman of the Board, and several senior management members plan to concurrently increase their holdings in the Company. The total maximum amount for the on-market buyback and senior management share purchases combined will be HK$56 million.

Tag： Laekna, Inc.02105.HK

08:15

【SF Intra-city (09699.HK): Total 19.11 Million Shares Purchased under H-Share Incentive Scheme at Total Cost of Approximately HK$193 Million】NewTimeSpace News: In a voluntary announcement dated July 2, SF Intra-city disclosed that between 1 September 2025 and 30 June 2026, the trustee purchased an aggregate of 19,113,800 shares in the market under the 2025 H-Share Incentive Scheme, at a total consideration of approximately HK$193 million.

Tag： SF INTRA-CITY 09699.HK

08:10

【Abbisko(02256.HK): Strategic Cooperation Reached with AstraZeneca to Advance Clinical Study of ABSK043 Combined with Tagrisso for NSCLC Treatment】NewTimeSpace News: In a voluntary announcement dated July 2, Abbisko disclosed that its subsidiary HORIZON Therapeutics entered into a strategic cooperation agreement with AstraZeneca to jointly conduct a multicenter, open-label Phase I/II clinical trial. The trial is designed to evaluate the safety and efficacy of ABSK043 (lumipodlin), the company’s proprietary first-in-class oral small-molecule PD-L1 inhibitor, in combination with AstraZeneca’s third-generation EGFR-TKI Tagrisso (osimertinib) for patients with EGFR-mutated, PD-L1-positive non-small cell lung cancer (NSCLC).

Tag： Abbisko 02256.HK

08:05

【Ribo Life Science(06938.HK): Milestone Achieved with Selection of First Candidate Drug under Collaboration with Madrigal】NewTimeSpace News: In a voluntary announcement dated July 2, Ribo Life Sciencedisclosed that the milestone of selecting the first candidate drug under its siRNA collaboration programme with Madrigal Pharmaceuticals has been accomplished, and IND-enabling studies will be launched immediately afterwards.

Tag： Ribo Life Science 06938.HK

07:59

【Ganfeng Lithium (01772.HK): Shareholder Wang Xiaoshen Pledges 5.7 Million Shares, Cumulative Pledge Ratio Accounts for 46.96% of His Shareholding】NewTimeSpace News: Ganfeng Lithium announced on July 2 that Mr. Wang Xiaoshen, a shareholder of the Company, pledged 5.7 million shares of the Company to Guotai Haitong Securities. The pledged shares account for 4.03% of his personal shareholding and 0.27% of the Company’s total issued share capital.

Tag： Ganfeng Lithium 01772.HK

07:55

【SSY Group Limited(02005.HK): Methocarbamol Tablets Approved for Marketing; Phloroglucinol API Granted Registration】NewTimeSpace News: In a voluntary announcement dated July 2, SSY Group Limiteddisclosed that the Group has obtained the drug manufacturing registration approval for Methocarbamol Tablets (0.5g) issued by the National Medical Products Administration (NMPA). Meanwhile, the Group’s phloroglucinol active pharmaceutical ingredient (API) has been approved for registration as an API for use in marketed pharmaceutical preparations.

Tag： SSY Group Limited 02005.HK

07:51

【Leads Biolabs(09887.HK): Grant of 2,254,691 H-share Awards to 149 Grantees】NewTimeSpace News: Leads Biolabsannounced on July 1 that pursuant to its H-share incentive scheme, the Company granted an aggregate of 2,254,691 share awards to 149 grantees.

Tag： Leads Biolabs 09887.HK